Verdad Advisers »

Vistagen Therapeutics Ord shares owned by Verdad Advisers

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $106k 185k 0.57

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Vistagen Therapeutics Ord

OrbiMed Advisors
TCG Crossover Management
Vanguard Capital Management
ADAR1 Capital Management
Millennium Management
Stempoint Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Geode Capital Management
BlackRock
Luminus Management
Jane Street
Renaissance Technologies
AdvisorShares Investments

View all funds holding Vistagen Therapeutics Ord